Persistent exaggerated granulomatous hypersensitivity reaction to Mycobacterium indicus pranii immunomodulatory therapy for COVID-19 sepsis
Saved in:
Main Authors: | Nikhil Mehta (Author), Mehul Tyagi (Author), Iftekhar Khan (Author), Neena Khanna (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobacterium indicus pranii vaccination-induced cutaneous granuloma in COVID-19 patients
by: Yapamakula Anisha Amarnath, et al.
Published: (2023) -
Pyoderma Gangrenosum Following Mycobacterium Indicus pranii Vaccination for COVID-19 Infection
by: Sukhdeep Singh, et al.
Published: (2024) -
Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine
by: Sunil Kumar Gupta, et al.
Published: (2022) -
Mycobacterium indicus pranii (MIP) vaccine: Pharmacology, indication, dosing schedules, administration, and side effects in clinical practice
by: Sunil Dogra, et al.
Published: (2023) -
Propofol Ameliorates Exaggerated Human Neutrophil Activation in a LPS Sepsis Model
by: Bredthauer A, et al.
Published: (2021)